Full List Of Stories
London close: Stocks mixed on return from long weekend
London’s financial markets closed with a mixed performance on Tuesday, with Bunzl underpinning gains on the top-flight index after upgrading its full-year outlook.
Next shop workers win landmark equal pay case
Shop workers at high-street retailer Next won a landmark legal victory on Tuesday, after a six-year battle for equal pay, potentially leading to over £30m in compensation.
Faron Pharmaceuticals candidate gets FDA fast track designation
Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Tuesday that its lead candidate, bexmarilimab, has been granted fast track designation by the US Food and Drug Administration (FDA), for the treatment of relapsed or refractory myelodysplastic syndrome (r/r MDS) in combination with azacitidine.
Prospex acquires 7.5pc stake in Viura gas field
Prospex Energy, an investment company focused on European gas and power projects, announced the successfully completed acquisition of a 7. 5% stake in Heyco Energy Iberia (HEI) on Tuesday, the majority owner of the Viura gas field in northern Spain.
Goldplat profitability improves in fourth quarter
South Africa and Ghana-focussed gold recovery specialist Goldplat announced a substantial increase in fourth-quarter profitability on Tuesday.
Diaceutics reports progress with rare-disease offerings
Diaceutics announced a significant enhancement to its rare-disease offerings on Tuesday, leading to the acquisition of a new contract aimed at supporting the commercialisation of a rare-disease therapy.
Belluscura shares surge on strong sales momentum, improved outlook
Belluscura, a developer of lightweight and portable oxygen enrichment technology, reported strong sales momentum and an optimistic trading outlook on Tuesday, as it prepared for the full commercial launch of its new ‘DISCOV-R’ portable oxygen concentrator.
RUA Life Sciences reports strong start to financial year
RUA Life Sciences, a medical device company specialising in implantable textiles and biostable polymers, reported a strong start to its financial year on Tuesday, with trading in the first four months exceeding management expectations.
Shield Therapeutics iron deficiency treatment approved in Canada
Commercial-stage pharmaceutical company Shield Therapeutics announced on Tuesday that ‘ACCRUFeR’, or ferric maltol, had been approved by Health Canada as a prescription drug for the treatment of adults with iron deficiency anaemia (IDA).
JD.com unveils $5bn, 36-month share buyback plans
Chinese e-commerce giant JD. com unveiled a new $5bn share buyback programme on Tuesday, set to begin in September and extend over the next 36 months.
Bronfman withdraws bid for Paramount, making way for Skydance deal
Edgar Bronfman Jr officially withdrew his bid to acquire Paramount Global on Tuesday, effectively clearing the way for Skydance Media to take control of the company.
Plus500 kicks off fresh $110m share buyback
Multi-asset fintech firm Plus500 announced the launch of a share buyback programme valued at up to $110m on Tuesday.
Asia report: Most markets follow Wall Street lower
Asia-Pacific markets largely fell on Tuesday, mirroring losses in key US indices overnight and reflecting cautious investor sentiment as they assessed mixed economic data from China and ongoing geopolitical tensions.
Bunzl shares jump on upgraded outlook, share buyback launch
Bunzl shares were surging on Tuesday morning after it upgraded its full-year guidance and launched a share buyback programme, even after first-half revenue slipped 3. 3% to £5. 71bn.
Bunzl revenue falls while profits improve, Ocado starts ops at Australia centres
London open The FTSE 100 is expected to open up 44 points on Tuesday, having closed down 0. 48% at 8,327. 78 ahead of the long weekend on Friday.
Shop prices fall for the first time since late 2021
Shop prices in the UK in August experienced deflation for the first time since October 2021, according to fresh data released on Tuesday, with a decrease of 0. 3%.